Author:
Latz Jane E,Karlsson Mats O,Rusthoven James J,Ghosh Atalanta,Johnson Robert D
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference55 articles.
1. Adjei AA (2003) Pemetrexed (Alimta): a novel multitargeted antifolate agent. Expert Rev Anticancer Ther 3:145–156
2. Alati T, Shih C, Pohland RC, Lantz FJ, Grindey GB (1992) Evaluation of the mechanism(s) of inhibition of the toxicity, but not the antitumor activity of lomotrexol (DDATHF) by folic acid. Proc Am Assoc Cancer Res 33:407
3. Alimta Drug Approval Package, Medical Review. Food and Drug Administration Web site. Available at: http://www.fda.gov/cder/foi/nda/2004/21-462.pdf_Alimta_Medr_P6.pdf. Page 257. Accessed September 20, 2004
4. Allen RH, Stabler SP, Savage DG, Lindenbaum J (1993) Metabolic abnormalities in cobalamin (vitamin B12) and folate deficiency. FASEB J 7:1344–1353
5. Bajetta E, Celio L, Buzzoni R et al (2003) Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer. Ann Oncol 14:1543–1548
Cited by
53 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献